Turkish Journal of Medical Sciences
Volume 34

Number 6

Article 13

1-1-2004

Alternative Testing Methods - Reproductive Toxicity
SRINIVASA JAYACHANDRA
MAXIM PINTO
URBAN J.A.D'SOUZA

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
JAYACHANDRA, SRINIVASA; PINTO, MAXIM; and J.A.D'SOUZA, URBAN (2004) "Alternative Testing
Methods - Reproductive Toxicity," Turkish Journal of Medical Sciences: Vol. 34: No. 6, Article 13. Available
at: https://journals.tubitak.gov.tr/medical/vol34/iss6/13

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turk J Med Sci
34 (2004) 419
© TÜB‹TAK

LETTER TO THE EDITOR

Alternative Testing Methods - Reproductive Toxicity

Srinivasa JAYACHANDRA1, Maxim PINTO2, Urban J.A. D`SOUZA3
1

Department of Medical Bioscience, Monash University Malaysia, 46150 Petaling Jaya - Malaysia
2
3

Wipro Technologies, Bangalore - India

Department of Physiology, Universiti Sains Malaysia, 16150 Kota Bharu - Malaysia

Received: September 27, 2004

Reproductive toxicity refers to the adverse effects of
a substance on any aspect of the reproductive cycle. There
are different conventional animal tests for assessing
reproductive toxicity like the prenatal developmental
toxicity study, the 1-generation study, the 2-generation
study, and the repeat-dose toxicity study. Now a days
there has been a considerable increase in the number of
in vivo screening tests to detect so-called endocrine
disruptors, which could replace reproductive toxicity
testing procedures using animals and would substantially
reduce the number of animals used for biomedical
testing. There are many other alternative methods for
reproductive toxicity testing, including the micromass
(MM) assay, the whole embryo culture (WEC) assay, the
embryonic stem cell test (EST), and the frog embryo
teratogenesis assay–Xenopus (FETAX) assay.
Brown (1) has already stated that “It is important that
these new strategies (embryonic approaches) are not
bedevilled by naive expectations, particularly in the early
stages of their use. The V word (validation) should be
locked away, in favor of ‘profiling’, in which we ask ‘Can
this chemical affect this particular pathway’?” Moreover,

he predicts that “Once answers are available for many
chemicals and pathways, patterns of response will be
assembled, and these may allow the prediction of some
types of developmental toxicity.”
It is also not possible to model the whole of the
reproductive cycle in vitro with one approach. The parts
of the system need to be studied individually and then
integrated into a testing strategy. It will take time to
develop and validate a battery of alternative tests that can
cover the various aspects of the reproductive cycle, and so
animal tests will continue to be required for the
foreseeable future, at least for certain aspects of
reproductive toxicity testing.
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